Literature DB >> 6835277

Oral contraceptives and ovarian cancer.

J T Casagrande, M C Pike, B E Henderson.   

Abstract

Entities:  

Keywords:  Acceptor Characteristics; Acceptors; Age Factors; Cancer; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Demographic Factors; Diseases; Family Planning; Family Planning Programs; Neoplasms; Oral Contraceptives--side effects; Ovarian Cancer; Population; Population Characteristics

Mesh：

Substances：

Year:  1983        PMID： 6835277     DOI： 10.1056/NEJM198304073081415

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.

Authors:  Celeste Leigh Pearce; Karine Chung; Malcolm C Pike; Anna H Wu
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

2.  Oral contraceptive use and the risk of epithelial ovarian cancer.

Authors:  C La Vecchia; S Franceschi; A Decarli
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.